Global Hepatitis B Vaccines Market Growth 2022-2028
As the global economy mends, the 2021 growth of Hepatitis B Vaccines will have significant change from previous year. According to our latest study, the global Hepatitis B Vaccines market size is USD million in 2022 from USD 999.6 million in 2021, with a change of % between 2021 and 2022. The global Hepatitis B Vaccines market size will reach USD 1137.8 million in 2028, growing at a CAGR of 1.9% over the analysis period.
The United States Hepatitis B Vaccines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Hepatitis B Vaccines market, reaching US$ million by the year 2028. As for the Europe Hepatitis B Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Hepatitis B Vaccines players cover GSK, NCPC, Merck, and Bio Kangtai, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Hepatitis B Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Yeast Derived
CHO Derived
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Children
Adult
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
GSK
NCPC
Merck
Bio Kangtai
Dynavax
Hissen
KM Biologics
LG Life Sciences
Serum Institute
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hepatitis B Vaccines Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Hepatitis B Vaccines by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Hepatitis B Vaccines by Country/Region, 2017, 2022 & 2028
2.2 Hepatitis B Vaccines Segment by Type
2.2.1 Yeast Derived
2.2.2 CHO Derived
2.3 Hepatitis B Vaccines Sales by Type
2.3.1 Global Hepatitis B Vaccines Sales Market Share by Type (2017-2022)
2.3.2 Global Hepatitis B Vaccines Revenue and Market Share by Type (2017-2022)
2.3.3 Global Hepatitis B Vaccines Sale Price by Type (2017-2022)
2.4 Hepatitis B Vaccines Segment by Application
2.4.1 Children
2.4.2 Adult
2.5 Hepatitis B Vaccines Sales by Application
2.5.1 Global Hepatitis B Vaccines Sale Market Share by Application (2017-2022)
2.5.2 Global Hepatitis B Vaccines Revenue and Market Share by Application (2017-2022)
2.5.3 Global Hepatitis B Vaccines Sale Price by Application (2017-2022)
3 Global Hepatitis B Vaccines by Company
3.1 Global Hepatitis B Vaccines Breakdown Data by Company
3.1.1 Global Hepatitis B Vaccines Annual Sales by Company (2020-2022)
3.1.2 Global Hepatitis B Vaccines Sales Market Share by Company (2020-2022)
3.2 Global Hepatitis B Vaccines Annual Revenue by Company (2020-2022)
3.2.1 Global Hepatitis B Vaccines Revenue by Company (2020-2022)
3.2.2 Global Hepatitis B Vaccines Revenue Market Share by Company (2020-2022)
3.3 Global Hepatitis B Vaccines Sale Price by Company
3.4 Key Manufacturers Hepatitis B Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hepatitis B Vaccines Product Location Distribution
3.4.2 Players Hepatitis B Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Hepatitis B Vaccines by Geographic Region
4.1 World Historic Hepatitis B Vaccines Market Size by Geographic Region (2017-2022)
4.1.1 Global Hepatitis B Vaccines Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Hepatitis B Vaccines Annual Revenue by Geographic Region
4.2 World Historic Hepatitis B Vaccines Market Size by Country/Region (2017-2022)
4.2.1 Global Hepatitis B Vaccines Annual Sales by Country/Region (2017-2022)
4.2.2 Global Hepatitis B Vaccines Annual Revenue by Country/Region
4.3 Americas Hepatitis B Vaccines Sales Growth
4.4 APAC Hepatitis B Vaccines Sales Growth
4.5 Europe Hepatitis B Vaccines Sales Growth
4.6 Middle East & Africa Hepatitis B Vaccines Sales Growth
5 Americas
5.1 Americas Hepatitis B Vaccines Sales by Country
5.1.1 Americas Hepatitis B Vaccines Sales by Country (2017-2022)
5.1.2 Americas Hepatitis B Vaccines Revenue by Country (2017-2022)
5.2 Americas Hepatitis B Vaccines Sales by Type
5.3 Americas Hepatitis B Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hepatitis B Vaccines Sales by Region
6.1.1 APAC Hepatitis B Vaccines Sales by Region (2017-2022)
6.1.2 APAC Hepatitis B Vaccines Revenue by Region (2017-2022)
6.2 APAC Hepatitis B Vaccines Sales by Type
6.3 APAC Hepatitis B Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Hepatitis B Vaccines by Country
7.1.1 Europe Hepatitis B Vaccines Sales by Country (2017-2022)
7.1.2 Europe Hepatitis B Vaccines Revenue by Country (2017-2022)
7.2 Europe Hepatitis B Vaccines Sales by Type
7.3 Europe Hepatitis B Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Hepatitis B Vaccines by Country
8.1.1 Middle East & Africa Hepatitis B Vaccines Sales by Country (2017-2022)
8.1.2 Middle East & Africa Hepatitis B Vaccines Revenue by Country (2017-2022)
8.2 Middle East & Africa Hepatitis B Vaccines Sales by Type
8.3 Middle East & Africa Hepatitis B Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hepatitis B Vaccines
10.3 Manufacturing Process Analysis of Hepatitis B Vaccines
10.4 Industry Chain Structure of Hepatitis B Vaccines
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hepatitis B Vaccines Distributors
11.3 Hepatitis B Vaccines Customer
12 World Forecast Review for Hepatitis B Vaccines by Geographic Region
12.1 Global Hepatitis B Vaccines Market Size Forecast by Region
12.1.1 Global Hepatitis B Vaccines Forecast by Region (2023-2028)
12.1.2 Global Hepatitis B Vaccines Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Hepatitis B Vaccines Forecast by Type
12.7 Global Hepatitis B Vaccines Forecast by Application
13 Key Players Analysis
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Hepatitis B Vaccines Product Offered
13.1.3 GSK Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 NCPC
13.2.1 NCPC Company Information
13.2.2 NCPC Hepatitis B Vaccines Product Offered
13.2.3 NCPC Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 NCPC Main Business Overview
13.2.5 NCPC Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Hepatitis B Vaccines Product Offered
13.3.3 Merck Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Bio Kangtai
13.4.1 Bio Kangtai Company Information
13.4.2 Bio Kangtai Hepatitis B Vaccines Product Offered
13.4.3 Bio Kangtai Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Bio Kangtai Main Business Overview
13.4.5 Bio Kangtai Latest Developments
13.5 Dynavax
13.5.1 Dynavax Company Information
13.5.2 Dynavax Hepatitis B Vaccines Product Offered
13.5.3 Dynavax Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Dynavax Main Business Overview
13.5.5 Dynavax Latest Developments
13.6 Hissen
13.6.1 Hissen Company Information
13.6.2 Hissen Hepatitis B Vaccines Product Offered
13.6.3 Hissen Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Hissen Main Business Overview
13.6.5 Hissen Latest Developments
13.7 KM Biologics
13.7.1 KM Biologics Company Information
13.7.2 KM Biologics Hepatitis B Vaccines Product Offered
13.7.3 KM Biologics Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 KM Biologics Main Business Overview
13.7.5 KM Biologics Latest Developments
13.8 LG Life Sciences
13.8.1 LG Life Sciences Company Information
13.8.2 LG Life Sciences Hepatitis B Vaccines Product Offered
13.8.3 LG Life Sciences Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 LG Life Sciences Main Business Overview
13.8.5 LG Life Sciences Latest Developments
13.9 Serum Institute
13.9.1 Serum Institute Company Information
13.9.2 Serum Institute Hepatitis B Vaccines Product Offered
13.9.3 Serum Institute Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Serum Institute Main Business Overview
13.9.5 Serum Institute Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Hepatitis B Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Hepatitis B Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Yeast Derived
Table 4. Major Players of CHO Derived
Table 5. Global Hepatitis B Vaccines Sales by Type (2017-2022) & (M Doses)
Table 6. Global Hepatitis B Vaccines Sales Market Share by Type (2017-2022)
Table 7. Global Hepatitis B Vaccines Revenue by Type (2017-2022) & ($ million)
Table 8. Global Hepatitis B Vaccines Revenue Market Share by Type (2017-2022)
Table 9. Global Hepatitis B Vaccines Sale Price by Type (2017-2022) & (USD/Doses)
Table 10. Global Hepatitis B Vaccines Sales by Application (2017-2022) & (M Doses)
Table 11. Global Hepatitis B Vaccines Sales Market Share by Application (2017-2022)
Table 12. Global Hepatitis B Vaccines Revenue by Application (2017-2022)
Table 13. Global Hepatitis B Vaccines Revenue Market Share by Application (2017-2022)
Table 14. Global Hepatitis B Vaccines Sale Price by Application (2017-2022) & (USD/Doses)
Table 15. Global Hepatitis B Vaccines Sales by Company (2020-2022) & (M Doses)
Table 16. Global Hepatitis B Vaccines Sales Market Share by Company (2020-2022)
Table 17. Global Hepatitis B Vaccines Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Hepatitis B Vaccines Revenue Market Share by Company (2020-2022)
Table 19. Global Hepatitis B Vaccines Sale Price by Company (2020-2022) & (USD/Doses)
Table 20. Key Manufacturers Hepatitis B Vaccines Producing Area Distribution and Sales Area
Table 21. Players Hepatitis B Vaccines Products Offered
Table 22. Hepatitis B Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Hepatitis B Vaccines Sales by Geographic Region (2017-2022) & (M Doses)
Table 26. Global Hepatitis B Vaccines Sales Market Share Geographic Region (2017-2022)
Table 27. Global Hepatitis B Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Hepatitis B Vaccines Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Hepatitis B Vaccines Sales by Country/Region (2017-2022) & (M Doses)
Table 30. Global Hepatitis B Vaccines Sales Market Share by Country/Region (2017-2022)
Table 31. Global Hepatitis B Vaccines Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Hepatitis B Vaccines Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Hepatitis B Vaccines Sales by Country (2017-2022) & (M Doses)
Table 34. Americas Hepatitis B Vaccines Sales Market Share by Country (2017-2022)
Table 35. Americas Hepatitis B Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Hepatitis B Vaccines Revenue Market Share by Country (2017-2022)
Table 37. Americas Hepatitis B Vaccines Sales by Type (2017-2022) & (M Doses)
Table 38. Americas Hepatitis B Vaccines Sales Market Share by Type (2017-2022)
Table 39. Americas Hepatitis B Vaccines Sales by Application (2017-2022) & (M Doses)
Table 40. Americas Hepatitis B Vaccines Sales Market Share by Application (2017-2022)
Table 41. APAC Hepatitis B Vaccines Sales by Region (2017-2022) & (M Doses)
Table 42. APAC Hepatitis B Vaccines Sales Market Share by Region (2017-2022)
Table 43. APAC Hepatitis B Vaccines Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Hepatitis B Vaccines Revenue Market Share by Region (2017-2022)
Table 45. APAC Hepatitis B Vaccines Sales by Type (2017-2022) & (M Doses)
Table 46. APAC Hepatitis B Vaccines Sales Market Share by Type (2017-2022)
Table 47. APAC Hepatitis B Vaccines Sales by Application (2017-2022) & (M Doses)
Table 48. APAC Hepatitis B Vaccines Sales Market Share by Application (2017-2022)
Table 49. Europe Hepatitis B Vaccines Sales by Country (2017-2022) & (M Doses)
Table 50. Europe Hepatitis B Vaccines Sales Market Share by Country (2017-2022)
Table 51. Europe Hepatitis B Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Hepatitis B Vaccines Revenue Market Share by Country (2017-2022)
Table 53. Europe Hepatitis B Vaccines Sales by Type (2017-2022) & (M Doses)
Table 54. Europe Hepatitis B Vaccines Sales Market Share by Type (2017-2022)
Table 55. Europe Hepatitis B Vaccines Sales by Application (2017-2022) & (M Doses)
Table 56. Europe Hepatitis B Vaccines Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Hepatitis B Vaccines Sales by Country (2017-2022) & (M Doses)
Table 58. Middle East & Africa Hepatitis B Vaccines Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Hepatitis B Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Hepatitis B Vaccines Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Hepatitis B Vaccines Sales by Type (2017-2022) & (M Doses)
Table 62. Middle East & Africa Hepatitis B Vaccines Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Hepatitis B Vaccines Sales by Application (2017-2022) & (M Doses)
Table 64. Middle East & Africa Hepatitis B Vaccines Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Hepatitis B Vaccines
Table 66. Key Market Challenges & Risks of Hepatitis B Vaccines
Table 67. Key Industry Trends of Hepatitis B Vaccines
Table 68. Hepatitis B Vaccines Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Hepatitis B Vaccines Distributors List
Table 71. Hepatitis B Vaccines Customer List
Table 72. Global Hepatitis B Vaccines Sales Forecast by Region (2023-2028) & (M Doses)
Table 73. Global Hepatitis B Vaccines Sales Market Forecast by Region
Table 74. Global Hepatitis B Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Hepatitis B Vaccines Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Hepatitis B Vaccines Sales Forecast by Country (2023-2028) & (M Doses)
Table 77. Americas Hepatitis B Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Hepatitis B Vaccines Sales Forecast by Region (2023-2028) & (M Doses)
Table 79. APAC Hepatitis B Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Hepatitis B Vaccines Sales Forecast by Country (2023-2028) & (M Doses)
Table 81. Europe Hepatitis B Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Hepatitis B Vaccines Sales Forecast by Country (2023-2028) & (M Doses)
Table 83. Middle East & Africa Hepatitis B Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Hepatitis B Vaccines Sales Forecast by Type (2023-2028) & (M Doses)
Table 85. Global Hepatitis B Vaccines Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Hepatitis B Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Hepatitis B Vaccines Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Hepatitis B Vaccines Sales Forecast by Application (2023-2028) & (M Doses)
Table 89. Global Hepatitis B Vaccines Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Hepatitis B Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Hepatitis B Vaccines Revenue Market Share Forecast by Application (2023-2028)
Table 92. GSK Basic Information, Hepatitis B Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 93. GSK Hepatitis B Vaccines Product Offered
Table 94. GSK Hepatitis B Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
Table 95. GSK Main Business
Table 96. GSK Latest Developments
Table 97. NCPC Basic Information, Hepatitis B Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 98. NCPC Hepatitis B Vaccines Product Offered
Table 99. NCPC Hepatitis B Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
Table 100. NCPC Main Business
Table 101. NCPC Latest Developments
Table 102. Merck Basic Information, Hepatitis B Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 103. Merck Hepatitis B Vaccines Product Offered
Table 104. Merck Hepatitis B Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
Table 105. Merck Main Business
Table 106. Merck Latest Developments
Table 107. Bio Kangtai Basic Information, Hepatitis B Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 108. Bio Kangtai Hepatitis B Vaccines Product Offered
Table 109. Bio Kangtai Hepatitis B Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
Table 110. Bio Kangtai Main Business
Table 111. Bio Kangtai Latest Developments
Table 112. Dynavax Basic Information, Hepatitis B Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 113. Dynavax Hepatitis B Vaccines Product Offered
Table 114. Dynavax Hepatitis B Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
Table 115. Dynavax Main Business
Table 116. Dynavax Latest Developments
Table 117. Hissen Basic Information, Hepatitis B Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 118. Hissen Hepatitis B Vaccines Product Offered
Table 119. Hissen Hepatitis B Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
Table 120. Hissen Main Business
Table 121. Hissen Latest Developments
Table 122. KM Biologics Basic Information, Hepatitis B Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 123. KM Biologics Hepatitis B Vaccines Product Offered
Table 124. KM Biologics Hepatitis B Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
Table 125. KM Biologics Main Business
Table 126. KM Biologics Latest Developments
Table 127. LG Life Sciences Basic Information, Hepatitis B Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 128. LG Life Sciences Hepatitis B Vaccines Product Offered
Table 129. LG Life Sciences Hepatitis B Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
Table 130. LG Life Sciences Main Business
Table 131. LG Life Sciences Latest Developments
Table 132. Serum Institute Basic Information, Hepatitis B Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 133. Serum Institute Hepatitis B Vaccines Product Offered
Table 134. Serum Institute Hepatitis B Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
Table 135. Serum Institute Main Business
Table 136. Serum Institute Latest Developments
List of Figures
Figure 1. Picture of Hepatitis B Vaccines
Figure 2. Hepatitis B Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hepatitis B Vaccines Sales Growth Rate 2017-2028 (M Doses)
Figure 7. Global Hepatitis B Vaccines Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Hepatitis B Vaccines Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Yeast Derived
Figure 10. Product Picture of CHO Derived
Figure 11. Global Hepatitis B Vaccines Sales Market Share by Type in 2021
Figure 12. Global Hepatitis B Vaccines Revenue Market Share by Type (2017-2022)
Figure 13. Hepatitis B Vaccines Consumed in Children
Figure 14. Global Hepatitis B Vaccines Market: Children (2017-2022) & (M Doses)
Figure 15. Hepatitis B Vaccines Consumed in Adult
Figure 16. Global Hepatitis B Vaccines Market: Adult (2017-2022) & (M Doses)
Figure 17. Global Hepatitis B Vaccines Sales Market Share by Application (2017-2022)
Figure 18. Global Hepatitis B Vaccines Revenue Market Share by Application in 2021
Figure 19. Hepatitis B Vaccines Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Hepatitis B Vaccines Revenue Market Share by Company in 2021
Figure 21. Global Hepatitis B Vaccines Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Hepatitis B Vaccines Revenue Market Share by Geographic Region in 2021
Figure 23. Global Hepatitis B Vaccines Sales Market Share by Region (2017-2022)
Figure 24. Global Hepatitis B Vaccines Revenue Market Share by Country/Region in 2021
Figure 25. Americas Hepatitis B Vaccines Sales 2017-2022 (M Doses)
Figure 26. Americas Hepatitis B Vaccines Revenue 2017-2022 ($ Millions)
Figure 27. APAC Hepatitis B Vaccines Sales 2017-2022 (M Doses)
Figure 28. APAC Hepatitis B Vaccines Revenue 2017-2022 ($ Millions)
Figure 29. Europe Hepatitis B Vaccines Sales 2017-2022 (M Doses)
Figure 30. Europe Hepatitis B Vaccines Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Hepatitis B Vaccines Sales 2017-2022 (M Doses)
Figure 32. Middle East & Africa Hepatitis B Vaccines Revenue 2017-2022 ($ Millions)
Figure 33. Americas Hepatitis B Vaccines Sales Market Share by Country in 2021
Figure 34. Americas Hepatitis B Vaccines Revenue Market Share by Country in 2021
Figure 35. United States Hepatitis B Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Hepatitis B Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Hepatitis B Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Hepatitis B Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Hepatitis B Vaccines Sales Market Share by Region in 2021
Figure 40. APAC Hepatitis B Vaccines Revenue Market Share by Regions in 2021
Figure 41. China Hepatitis B Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Hepatitis B Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Hepatitis B Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Hepatitis B Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Hepatitis B Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Hepatitis B Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Hepatitis B Vaccines Sales Market Share by Country in 2021
Figure 48. Europe Hepatitis B Vaccines Revenue Market Share by Country in 2021
Figure 49. Germany Hepatitis B Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Hepatitis B Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Hepatitis B Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Hepatitis B Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Hepatitis B Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Hepatitis B Vaccines Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Hepatitis B Vaccines Revenue Market Share by Country in 2021
Figure 56. Egypt Hepatitis B Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Hepatitis B Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Hepatitis B Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Hepatitis B Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Hepatitis B Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Hepatitis B Vaccines in 2021
Figure 62. Manufacturing Process Analysis of Hepatitis B Vaccines
Figure 63. Industry Chain Structure of Hepatitis B Vaccines
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
